Journal article
Tumor heterogeneity: does it matter?
- Abstract:
-
Introduction: It has long been recognized that tumors are composed of a mosaic of cells and numerous methods have been developed to detect tumor heterogeneity, including in situ hybridization, multi-regional sampling, cytological assays, and whole genome and single cell sequencing. Using these methods, heterogeneity has been observed at the genetic, epigenetic, and phenotypic level in numerous cancers. With the advent of deep sequencing technology, we now appreciate a gr... Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Accepted manuscript, pdf, 841.7KB)
-
- Publisher copy:
- 10.1080/14737140.2019.1667236
Authors
Bibliographic Details
- Publisher:
- Taylor and Francis Publisher's website
- Journal:
- Expert Review of Anticancer Therapy Journal website
- Volume:
- 19
- Issue:
- 10
- Pages:
- 857-867
- Publication date:
- 2019-09-11
- Acceptance date:
- 2019-09-10
- DOI:
- EISSN:
-
1744-8328
- ISSN:
-
1473-7140
- Pmid:
-
31510810
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:1054718
- UUID:
-
uuid:09b35e48-9443-41eb-8151-7c500fa471fb
- Local pid:
- pubs:1054718
- Source identifiers:
-
1054718
- Deposit date:
- 2020-01-15
Terms of use
- Copyright holder:
- Informa UK
- Copyright date:
- 2019
- Rights statement:
- © 2019 Informa UK Limited, trading as Taylor & Francis Group
- Notes:
- This is the accepted manuscript version of the article. The final version is available from Taylor and Francis at: https://doi.org/10.1080/14737140.2019.1667236
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record